Johns Hopkins ABX Guide
Aztreonam and avibactam
INDICATIONS
FDA
FDA
- Emblaveo (Aztreonam/Avibactam) is indicated in patients 18 years of age and older who have limited to no alternative treatment options for the treatment of complicated intra-abdominal infections (cIAI)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Resistant Gram-negative infections caused by metallo-β-lactamase producing organisms (e.g., NDM)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: June 11, 2025
Citation
Dzintars, Kathryn. "Aztreonam and Avibactam." Johns Hopkins ABX Guide, The Johns Hopkins University, 2025. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540801/all/Aztreonam_and_avibactam.
Dzintars K. Aztreonam and avibactam. Johns Hopkins ABX Guide. The Johns Hopkins University; 2025. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540801/all/Aztreonam_and_avibactam. Accessed July 27, 2025.
Dzintars, K. (2025). Aztreonam and avibactam. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540801/all/Aztreonam_and_avibactam
Dzintars K. Aztreonam and Avibactam [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2025. [cited 2025 July 27]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540801/all/Aztreonam_and_avibactam.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aztreonam and avibactam
ID - 540801
A1 - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2025/06/11/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540801/all/Aztreonam_and_avibactam
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
